# Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in Italy

> **NCT03005769** · — · COMPLETED · sponsor: **Otsuka Pharmaceutical Europe Ltd** · enrollment: 262 (actual)

## Conditions studied

- Schizophrenia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03005769
- **Lead sponsor:** Otsuka Pharmaceutical Europe Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 262 (ACTUAL)
- **Last updated:** 2017-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03005769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03005769, "Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in Italy". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03005769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*